Cargando…
Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
PURPOSE: To probabilistically forecast needed anti-vascular endothelial growth factor (anti-VEGF) treatment frequency using volumetric spectral domain–optical coherence tomography (SD-OCT) biomarkers in neovascular age-related macular degeneration from real-world settings. METHODS: SD-OCT volume sca...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254013/ https://www.ncbi.nlm.nih.gov/pubmed/34185055 http://dx.doi.org/10.1167/tvst.10.7.30 |
_version_ | 1783717638503923712 |
---|---|
author | Pfau, Maximilian Sahu, Soumya Rupnow, Rawan Allozi Romond, Kathleen Millet, Desiree Holz, Frank G. Schmitz-Valckenberg, Steffen Fleckenstein, Monika Lim, Jennifer I. de Sisternes, Luis Leng, Theodore Rubin, Daniel L. Hallak, Joelle A. |
author_facet | Pfau, Maximilian Sahu, Soumya Rupnow, Rawan Allozi Romond, Kathleen Millet, Desiree Holz, Frank G. Schmitz-Valckenberg, Steffen Fleckenstein, Monika Lim, Jennifer I. de Sisternes, Luis Leng, Theodore Rubin, Daniel L. Hallak, Joelle A. |
author_sort | Pfau, Maximilian |
collection | PubMed |
description | PURPOSE: To probabilistically forecast needed anti-vascular endothelial growth factor (anti-VEGF) treatment frequency using volumetric spectral domain–optical coherence tomography (SD-OCT) biomarkers in neovascular age-related macular degeneration from real-world settings. METHODS: SD-OCT volume scans were segmented with a custom deep-learning-based analysis pipeline. Retinal thickness and reflectivity values were extracted for the central and the four inner Early Treatment Diabetic Retinopathy Study (ETDRS) subfields for six retinal layers (inner retina, outer nuclear layer, inner segments [IS], outer segments [OS], retinal pigment epithelium-drusen complex [RPEDC] and the choroid). Machine-learning models were probed to predict the anti-VEGF treatment frequency within the next 12 months. Probabilistic forecasting was performed using natural gradient boosting (NGBoost), which outputs a full probability distribution. The mean absolute error (MAE) between the predicted versus actual anti-VEGF treatment frequency was the primary outcome measure. RESULTS: In a total of 138 visits of 99 eyes with neovascular AMD (96 patients) from two clinical centers, the prediction of future anti-VEGF treatment frequency was observed with an accuracy (MAE [95% confidence interval]) of 2.60 injections/year [2.25–2.96] (R(2) = 0.390) using random forest regression and 2.66 injections/year [2.31–3.01] (R(2) = 0.094) using NGBoost, respectively. Prediction intervals were well calibrated and reflected the true uncertainty of NGBoost-based predictions. Standard deviation of RPEDC-thickness in the central ETDRS-subfield constituted an important predictor across models. CONCLUSIONS: The proposed, fully automated pipeline enables probabilistic forecasting of future anti-VEGF treatment frequency in real-world settings. TRANSLATIONAL RELEVANCE: Prediction of a probability distribution allows the physician to inspect the underlying uncertainty. Predictive uncertainty estimates are essential to highlight cases where human-inspection and/or reversion to a fallback alternative is warranted. |
format | Online Article Text |
id | pubmed-8254013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Association for Research in Vision and Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-82540132021-07-08 Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration Pfau, Maximilian Sahu, Soumya Rupnow, Rawan Allozi Romond, Kathleen Millet, Desiree Holz, Frank G. Schmitz-Valckenberg, Steffen Fleckenstein, Monika Lim, Jennifer I. de Sisternes, Luis Leng, Theodore Rubin, Daniel L. Hallak, Joelle A. Transl Vis Sci Technol Article PURPOSE: To probabilistically forecast needed anti-vascular endothelial growth factor (anti-VEGF) treatment frequency using volumetric spectral domain–optical coherence tomography (SD-OCT) biomarkers in neovascular age-related macular degeneration from real-world settings. METHODS: SD-OCT volume scans were segmented with a custom deep-learning-based analysis pipeline. Retinal thickness and reflectivity values were extracted for the central and the four inner Early Treatment Diabetic Retinopathy Study (ETDRS) subfields for six retinal layers (inner retina, outer nuclear layer, inner segments [IS], outer segments [OS], retinal pigment epithelium-drusen complex [RPEDC] and the choroid). Machine-learning models were probed to predict the anti-VEGF treatment frequency within the next 12 months. Probabilistic forecasting was performed using natural gradient boosting (NGBoost), which outputs a full probability distribution. The mean absolute error (MAE) between the predicted versus actual anti-VEGF treatment frequency was the primary outcome measure. RESULTS: In a total of 138 visits of 99 eyes with neovascular AMD (96 patients) from two clinical centers, the prediction of future anti-VEGF treatment frequency was observed with an accuracy (MAE [95% confidence interval]) of 2.60 injections/year [2.25–2.96] (R(2) = 0.390) using random forest regression and 2.66 injections/year [2.31–3.01] (R(2) = 0.094) using NGBoost, respectively. Prediction intervals were well calibrated and reflected the true uncertainty of NGBoost-based predictions. Standard deviation of RPEDC-thickness in the central ETDRS-subfield constituted an important predictor across models. CONCLUSIONS: The proposed, fully automated pipeline enables probabilistic forecasting of future anti-VEGF treatment frequency in real-world settings. TRANSLATIONAL RELEVANCE: Prediction of a probability distribution allows the physician to inspect the underlying uncertainty. Predictive uncertainty estimates are essential to highlight cases where human-inspection and/or reversion to a fallback alternative is warranted. The Association for Research in Vision and Ophthalmology 2021-06-29 /pmc/articles/PMC8254013/ /pubmed/34185055 http://dx.doi.org/10.1167/tvst.10.7.30 Text en Copyright 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Article Pfau, Maximilian Sahu, Soumya Rupnow, Rawan Allozi Romond, Kathleen Millet, Desiree Holz, Frank G. Schmitz-Valckenberg, Steffen Fleckenstein, Monika Lim, Jennifer I. de Sisternes, Luis Leng, Theodore Rubin, Daniel L. Hallak, Joelle A. Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration |
title | Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration |
title_full | Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration |
title_fullStr | Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration |
title_full_unstemmed | Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration |
title_short | Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration |
title_sort | probabilistic forecasting of anti-vegf treatment frequency in neovascular age-related macular degeneration |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254013/ https://www.ncbi.nlm.nih.gov/pubmed/34185055 http://dx.doi.org/10.1167/tvst.10.7.30 |
work_keys_str_mv | AT pfaumaximilian probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration AT sahusoumya probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration AT rupnowrawanallozi probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration AT romondkathleen probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration AT milletdesiree probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration AT holzfrankg probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration AT schmitzvalckenbergsteffen probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration AT fleckensteinmonika probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration AT limjenniferi probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration AT desisternesluis probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration AT lengtheodore probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration AT rubindaniell probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration AT hallakjoellea probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration |